CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- 4 Open-market buy President & CEO bought 4,300 shares at an average $9.57 ($41,150)
- 4 Open-market buy Director bought 800 shares at $9.50 ($7,600)
- 4 Open-market buy President & CEO bought 1,000 shares at $9.50 ($9,500)
- 4 Open-market buy President & CEO bought 600 shares at $9.50 ($5,700)
- 4 Open-market buy President & CEO bought 2,100 shares at an average $9.77 ($20,524)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $9.80 ($4,900)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
Page 41 of 50 · 1,000 filings